Annual EPS
-$4.45
+$1.70+27.64%
31 December 2023
Summary:
Apellis Pharmaceuticals annual earnings per share is currently -$4.45, with the most recent change of +$1.70 (+27.64%) on 31 December 2023. During the last 3 years, it has risen by +$0.14 (+3.05%). APLS annual EPS is now -1931.96% below its all-time high of -$0.22, reached on 31 December 2013.APLS EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.46
-$0.16-53.33%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly earnings per share is currently -$0.46, with the most recent change of -$0.16 (-53.33%) on 30 September 2024. Over the past year, it has increased by +$0.71 (+60.68%). APLS quarterly EPS is now -143.40% below its all-time high of $1.06, reached on 31 December 2020.APLS Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$2.03
+$0.71+25.91%
30 September 2024
Summary:
Apellis Pharmaceuticals TTM earnings per share is currently -$2.03, with the most recent change of +$0.71 (+25.91%) on 30 September 2024. Over the past year, it has increased by +$3.22 (+61.33%). APLS TTM EPS is now -1387.18% below its all-time high of -$0.14, reached on 30 September 2014.APLS TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.6% | +60.7% | +61.3% |
| 3 y3 years | +3.0% | +79.8% | +67.6% |
| 5 y5 years | -90.2% | +58.2% | +45.7% |
APLS EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +49.7% | -53.3% | +79.8% | at high | +77.1% |
| 5 y | 5 years | -90.2% | +49.7% | -143.4% | +83.1% | at high | +77.1% |
| alltime | all time | -1932.0% | +49.7% | -143.4% | +83.1% | -1387.2% | +77.1% |
Apellis Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.46(+53.3%) | -$2.03(-25.9%) |
| June 2024 | - | -$0.30(-44.4%) | -$2.74(-20.8%) |
| Mar 2024 | - | -$0.54(-26.0%) | -$3.46(-22.8%) |
| Dec 2023 | -$4.45(-27.6%) | -$0.73(-37.6%) | -$4.48(-14.7%) |
| Sept 2023 | - | -$1.17(+14.7%) | -$5.25(-9.9%) |
| June 2023 | - | -$1.02(-34.6%) | -$5.83(-7.0%) |
| Mar 2023 | - | -$1.56(+4.0%) | -$6.27(+2.3%) |
| Dec 2022 | -$6.15(-30.4%) | -$1.50(-14.3%) | -$6.13(-0.5%) |
| Sept 2022 | - | -$1.75(+19.9%) | -$6.16(-7.9%) |
| June 2022 | - | -$1.46(+2.8%) | -$6.69(-15.8%) |
| Mar 2022 | - | -$1.42(-7.2%) | -$7.95(-10.2%) |
| Dec 2021 | -$8.84(+92.6%) | -$1.53(-32.9%) | -$8.85(+41.4%) |
| Sept 2021 | - | -$2.28(-16.2%) | -$6.26(+8.5%) |
| June 2021 | - | -$2.72(+17.2%) | -$5.77(+24.9%) |
| Mar 2021 | - | -$2.32(-318.9%) | -$4.62(+0.7%) |
| Dec 2020 | -$4.59(-6.3%) | $1.06(-159.2%) | -$4.59(-40.9%) |
| Sept 2020 | - | -$1.79(+14.0%) | -$7.76(+9.8%) |
| June 2020 | - | -$1.57(-31.4%) | -$7.07(+6.8%) |
| Mar 2020 | - | -$2.29(+8.5%) | -$6.62(+27.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$4.90(+109.4%) | -$2.11(+91.8%) | -$5.20(+39.0%) |
| Sept 2019 | - | -$1.10(-1.8%) | -$3.74(+14.0%) |
| June 2019 | - | -$1.12(+28.7%) | -$3.28(+18.4%) |
| Mar 2019 | - | -$0.87(+33.8%) | -$2.77(+18.9%) |
| Dec 2018 | -$2.34(-36.4%) | -$0.65(+1.6%) | -$2.33(+14.1%) |
| Sept 2018 | - | -$0.64(+4.9%) | -$2.04(+19.9%) |
| June 2018 | - | -$0.61(+41.9%) | -$1.70(-3.4%) |
| Mar 2018 | - | -$0.43(+18.6%) | -$1.76(-3.8%) |
| Dec 2017 | -$3.68(+145.5%) | -$0.36(+20.8%) | -$1.83(-0.2%) |
| Sept 2017 | - | -$0.30(-55.2%) | -$1.84(-5.1%) |
| June 2017 | - | -$0.67(+34.0%) | -$1.93(+53.0%) |
| Mar 2017 | - | -$0.50(+36.7%) | -$1.26(+65.4%) |
| Dec 2016 | -$1.50(-41.7%) | -$0.37(-8.2%) | -$0.76(-10.3%) |
| Sept 2016 | - | -$0.40(-12.2%) | -$0.85(-60.9%) |
| Dec 2015 | -$2.57(+331.1%) | -$0.45(-73.7%) | -$2.18(+16.3%) |
| Sept 2015 | - | -$1.72(+1060.0%) | -$1.87(+556.8%) |
| Dec 2014 | -$0.60(+172.3%) | -$0.15(+8.9%) | -$0.29(+108.9%) |
| Sept 2014 | - | -$0.14 | -$0.14 |
| Dec 2013 | -$0.22 | - | - |
FAQ
- What is Apellis Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual EPS year-on-year change?
- What is Apellis Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly EPS year-on-year change?
- What is Apellis Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM EPS year-on-year change?
What is Apellis Pharmaceuticals annual earnings per share?
The current annual EPS of APLS is -$4.45
What is the all time high annual EPS for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual earnings per share is -$0.22
What is Apellis Pharmaceuticals annual EPS year-on-year change?
Over the past year, APLS annual earnings per share has changed by +$1.70 (+27.64%)
What is Apellis Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of APLS is -$0.46
What is the all time high quarterly EPS for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly earnings per share is $1.06
What is Apellis Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, APLS quarterly earnings per share has changed by +$0.71 (+60.68%)
What is Apellis Pharmaceuticals TTM earnings per share?
The current TTM EPS of APLS is -$2.03
What is the all time high TTM EPS for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM earnings per share is -$0.14
What is Apellis Pharmaceuticals TTM EPS year-on-year change?
Over the past year, APLS TTM earnings per share has changed by +$3.22 (+61.33%)